医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Advanced Sterilization Products on Preventing the Spread of Coronavirus from Contaminated Medical Devices

2020年02月07日 AM07:52
このエントリーをはてなブックマークに追加


 

IRVINE, Calif.

Advanced Sterilization Products (ASP) released today an interview with experts Ryan Lewis, M.D., Senior Director of Medical Affairs and Medical Safety, and Jeremy Yarwood, Vice President of Research and Development.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200206006009/en/

Advanced Sterilization Products on Preventing the Spread of Coronavirus from Contaminated Medical Devices (Photo: Business Wire)

Advanced Sterilization Products on Preventing the Spread of Coronavirus from Contaminated Medical Devices (Photo: Business Wire)

On January 30, 2020 the World Health Organization (WHO) declared the recent outbreak of novel coronavirus a global emergency.* This measure, taken only five times in the history of the WHO, occurs when an extraordinary event is determined to constitute a public health risk through the international spread of disease. As suspected and confirmed cases grow in China and around the world, healthcare professionals globally are reviewing their risk management programs to ensure readiness for a potentially-serious, rapid contagion.

“Devices such as bronchoscopes, ENT flexible endoscopes and laryngoscopes are used for the diagnosis and treatment of patients with advanced coronavirus infections,” remarked Ryan Lewis, M.D. “These devices are reusable and must be disinfected or sterilized between uses. A high number of patients needing advanced care for coronavirus could result in a single device being used multiple times a day.”

Jeremy Yarwood gave details on how healthcare professionals process medical equipment that has been exposed to coronavirus in order to protect patients and staff, and noted how his company is working to help healthcare officials who are dealing with this contagion. “ASP is actively working with regulators and healthcare providers across the world and specifically in China to provide products that can aid reducing or preventing the spread of infection.”

To read the full interview with these ASP experts, visit www.asp.com/preventing-the-spread-of-coronavirus-from-contaminated-medical-devices.

*World Health Organization. (2019, January 30). Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV) [Press release]. Retrieved from https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)

ABOUT ADVANCED STERILIZATION PRODUCTS (ASP)

Advanced Sterilization Products (ASP) has a long track record of designing and delivering innovative infection prevention solutions that dramatically raise the level of health care and safety for those who matter most. Our pioneering technology, global distribution and established leadership position enable us to simplify the process of buying and operating infection prevention products and services every day for thousands of medical facilities around the world. This enables our customers to focus on what they do best – preventing infection and saving lives. For more information, please visit www.ASP.com.

©ASP 2019. All rights reserved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200206006009/en/

CONTACT

Advanced Sterilization Products

Mandy Allen

Director, Commercial Marketing

ASP-media@asp.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • TIENS Group will Become a Global Participant in the Future Massive Health Industry
  • エンヨ・ファーマがB型慢性肝炎患者でVonafexor(EYP001)を検討中の第2a相試験2件から得た16週目のトップライン中間解析結果を発表
  • Dr. Reddy’s Announces the Re-Launch of Over-the-Counter Naproxen Sodium Tablets USP, 220 mg, Store-Brand Equivalent of Aleve® in the U.S. Market
  • WNS Launches PRECIZON to Deliver Cloud-based Competitive Intelligence for Life Sciences Industry
  • Arcturus Announces Approval of Singapore Clinical Trial Application to Advance ARCT-154 and ARCT-165, Next Generation STARR™ mRNA Vaccines Targeting SARS-CoV-2 Variants of Concern, in a Phase 1/2 Study